ISDA

Entry Detail

PDB ID:

3RJ7

Keywords:

Title:

Human carbonic anhydrase II complexed with its inhibitor rhenium(I)triscarbonyl-cyclopentadienyl-carboxy-4-aminomethylbenzene-sulfonamide

Biological Source:

Source Organism:

Homo sapiens

PDB Version:

Deposition Date:

2011-04-15

Release Date:

2012-02-29

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.20 Å

R-Value Free:

0.19

R-Value Work:

0.16

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Carbonic anhydrase 2
Chain IDs:A
Chain Length:258
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00918 Pfam ID:PF00194 EC:4.2.1.1

Ligand Molecules

DMS

MBO

RCS

Primary Citation

[(Cp-R)M(CO)(3) ] (M=Re or (99m) Tc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX.

Can, D, Spingler, B, Schmutz, P, Mendes, F, Raposinho, P, Fernandes, C, Carta, F, Innocenti, A, Santos, I, Supuran, C.T, Alberto, R.Show

Angew.Chem.Int.Ed.Engl. 51 3354 3357 (2012)

PMID: 22344779 DOI: 10.1002/anie.201107333

Abstact

Enhanced receptor selectivity: carbonic anhydrase inhibitors are relevant for both cancer diagnosis and therapy. Combining non-radioactive Re compounds with their radioactive (99m)Tc homologs enables the use of identical molecules for therapy and imaging (theragnostic). The syntheses and in vitro evaluation of [(Cp-R)M(CO)(3)] (Cp=cyclopentadienyl, M=Re, (99m)Tc) with R being a highly potent carbonic-anhydrase-targeting vector is reported.

Legend

Protein

Chemical

Disease

Primary Citation of related structures